Physician profile
Stephen W Eubanks
NPI 1942302799
$2,385.83
in general payments reported to CMS, 2019-2025
28 companies · $62.54 in 2025
The $62.54 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $343 · 2021: $275 · 2022: $396 · 2023: $387 · 2024: $356 · 2025: $62.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $804.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $570.52 | 2019-2024 | |
| Janssen Biotech, INC. | $167.71 | 2019-2022 | |
| Genzyme Corporation | $161.72 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $136.43 | 2020-2024 | Dupixent |
| Lilly USA, LLC | $122.30 | 2019-2023 | Olumiant |
| Teleflex LLC | $111.83 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Janssen Scientific Affairs, LLC | $101.48 | 2019 | |
| Ucb, INC. | $97.76 | 2022-2023 | Cimzia |
| Biofrontera INC. | $79.77 | 2019-2021 | |
| Pfizer INC. | $79.69 | 2019-2023 | |
| Baxter Healthcare | $79.42 | 2019-2020 | |
| Allergan, INC. | $66.99 | 2021 | |
| Incyte Corporation | $66.99 | 2022-2024 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $59.77 | 2020-2023 | Jublia, Arazlo, Duobrii |
| Leo Pharma INC. | $59.60 | 2020-2023 | Adbry |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $58.83 | 2024 | |
| Sun Pharmaceutical Industries INC. | $57.38 | 2019-2022 | |
| Genentech USA, INC. | $47.42 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $43.87 | 2021 | |
| Merz North America, INC. | $36.64 | 2021 | |
| Almirall LLC | $35.21 | 2021-2024 | Seysara |
| E.R. Squibb & Sons, L.L.C. | $24.30 | 2024 | Sotyktu |
| Strata Skin Sciences, INC. | $22.28 | 2020 | |
| Dusa Pharmaceuticals, INC. | $22.01 | 2019 | |
| Dermira, INC. | $21.61 | 2019 | |
| Celgene Corporation | $19.16 | 2019 | |
| Arcutis Biotherapeutics, INC. | $19.11 | 2023 | |
| Verrica Pharmaceuticals INC. | $16.03 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Eubanks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.